Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 12 (NDUFA5P12)
- Target
- NDUFA5P12
- Molecular classification
- Other (Pseudogene)
01
Overview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 12 (NDUFA5P12) is a pseudogene that resembles the protein-coding gene for NADH:ubiquinone oxidoreductase subunit A5, which is a component of mitochondrial complex I involved in the electron transport chain[1][3]. However, NDUFA5P12 contains sequence defects that prevent it from producing a functional protein, and it is not known to have a direct role in cellular metabolism or disease. While some pseudogenes can participate in regulatory RNA networks, no specific regulatory or pathophysiological function is currently ascribed to NDUFA5P12[1][3][5].
02
Mechanism of action
None (No drugs or mechanisms of action as this is not an active protein or functional target.)
03
Biological functions
Other (Pseudogenes typically have no encoded protein function. However, some pseudogenes may play roles in gene regulation, such as acting as competing endogenous RNAs for microRNAs[5]. No specific function described for NDUFA5P12 itself.)
04
Disease associations
Other (No direct disease association or role reported for NDUFA5P12. In general, some pseudogenes can modulate disease processes through RNA-based mechanisms, but evidence for this specific pseudogene is lacking[5].)
05
Safety considerations
No known safety issues or therapeutic challenges, since it is not a drug target.
Beyond the preview
Go deeper on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 12 (NDUFA5P12).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 12 (NDUFA5P12).